Happy Thursday! It’s March 6th, 2025. Here’s a roundup of today’s essential food safety stories. Let’s get into the news.

What to know: Inspectors with the Food and Drug Administration are tracking a new outbreak of infections from Listeria monocytogenes.

So far there are three confirmed patients. The FDA has not reported the ages of the patients or where they live.

The company behind the deadly 2022 infant formula outbreak and recall situation was represented by the man expected to be appointed to lead the FDA division that oversees food safety.

Kyle Diamantas, who joined the FDA as interim leader of the agency’s food division, was most recently a corporate attorney with the Miami law firm Jones Day where he represented Abbott Nutrition, the manufacturer of infant formula behind the outbreak of cronobacter infections.

The latest data on antimicrobial resistance (AMR) in bacteria from humans, animals, and foods in Europe has been released.

Resistance to commonly used antimicrobials such as ampicillin, tetracyclines, and sulfonamides remains high in humans and animals for key pathogens like Salmonella and Campylobacter.

What to know: The number of food incidents possibly affecting Hong Kong increased in 2024, according to the Centre for Food Safety (CFS).

The Food Incident Surveillance System (FISS) monitors issues outside Hong Kong that potentially affect domestic food safety.

Stay Ahead with FSN Alerts

Get instant alerts on critical food safety outbreaks and recalls to keep you informed and protected. Stay ahead of the latest risks with real-time updates from Food Safety News.

Recent Recalls

You’re all caught up! We’ll be back tomorrow with the latest updates on food safety around the world. — Food Safety News Team

Daily Poll

How did you like today's newsletter?

Login or Subscribe to participate

Don’t forget…

Do you know someone who would like this newsletter? Share it with them.

Interested in reaching food safety curious readers like you? To become a Food Safety News partner, apply here.

Reply

or to participate

Keep Reading

No posts found